The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Caveolin-1 Gene Disruption Promotes Mammary Tumorigenesis and Dramatically Enhances Lung Metastasis in Vivo
Open accessAbstract
Caveolin-1 (Cav-1) is the principal structural component of caveolae membrane domains in non-muscle cells, including mammary epithelia. There is now clear evidence that caveolin-1 influences the development of human cancers. For example, a dominant-negative mutation (P132L) in the Cav-1 gene has been detected in up to 16% of human breast cancer samples. However, the exact functional role of caveolin-1 remains controversial. Mechanistically, in cultured cell models, Cav-1 is known to function as a negative regulator of the Rasp42/44 MAP kinase cascade and as a transcriptional repressor of cyclin D1 gene expression, possibly explaining its in vitro transformation suppressor activity. Genetic validation of this hypothesis at the in vivo and whole organismal level has been prevented by the lack of a Cav-1 (-/-)-null mouse model. Here, we examined the role of caveolin-1 in mammary tumorigenesis and lung metastasis using a molecular genetic approach. We interbred a well characterized transgenic mouse model of breast cancer, MMTV-PyMT (mouse mammary tumor virus-polyoma middle T antigen), with Cav-1 (-/-)-null mice. Then, we followed the onset and progression of mammary tumors and lung metastases in female mice over a 14-week period. Interestingly, PyMT/Cav-1 (-/-) mice showed an accelerated onset of mammary tumors, with increased multiplicity and tumor burden ( approximately 2-fold). No significant differences were detected between PyMT/Cav-1 (+/+) and PyMT/Cav-1 (+/-) mice, indicating that complete loss of caveolin-1 is required to accelerate both tumorigenesis and metastasis. Molecularly, mammary tumor samples derived from PyMT/Cav-1 (-/-) mice showed ERK-1/2 hyperactivation, cyclin D1 up-regulation, and Rb hyperphosphorylation, consistent with dys-regulated cell proliferation. PyMT/Cav-1 (-/-) mice also developed markedly advanced metastatic lung disease. Conversely, recombinant expression of Cav-1 in a highly metastatic PyMT mammary carcinoma-derived cell line, namely Met-1 cells, suppressed lung metastasis by approximately 4.5-fold. In vitro, these Cav-1-expressing Met-1 cells (Met-1/Cav-1) demonstrated a approximately 4.8-fold reduction in invasion through Matrigel-coated membranes. Interestingly, delivery of a cell permeable peptide encoding the caveolin-1 scaffolding domain (residues 82-101) into Met-1 cells was sufficient to inhibit invasion. Coincident with this decreased invasive index, Met-1/Cav-1 cells exhibited marked reductions in MMP-9 and MMP-2 secretion and associated gelatinolytic activity, as well as diminished ERK-1/2 signaling in response to growth factor stimulation. These results demonstrate, for the first time, that caveolin-1 is a potent suppressor of mammary tumor growth and metastasis using novel in vivo animal model approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Cowley, S. (1994) · Cell · doi:10.1016/0092-8674(94)90133-3 · Cited by 1,966
A rapid in vitro assay for quantitating the invasive potential of tumor cells.
Albini, A., Iwamoto, Y., Hk, K., Gr, M., Aaronson, S. A., Jm, K., & McEwan, R. N. (1987) · PubMed · Cited by 1,778
Guy, C. T., Cardiff, R. D., & Muller, W. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.954 · Cited by 1,631
Self-citationMechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase
Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A., & Goldberg, G. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5331 · Cited by 1,593
Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice
Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F. C., et al. (2001) · Science · doi:10.1126/science.1062688 · Cited by 1,552
Okamoto, T., Schlegel, A., Scherer, P. E., & Lisanti, M. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5419 · Cited by 1,498
Self-citationThe SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain
Marais, R., Wynne, J., & Treisman, R. (1993) · Cell · doi:10.1016/0092-8674(93)90237-k · Cited by 1,275
Cyclin D1 Expression Is Regulated Positively by the p42/p44 and Negatively by the p38/HOG Pathway
Lavoie, J. N., L'Allemain, G., Brunet, A., Müller, R., & Pouysségur, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20608 · Cited by 1,211
Caveolin-1 Null Mice Are Viable but Show Evidence of Hyperproliferative and Vascular Abnormalities
Razani, B., Engelman, J. A., Wang, X. B., Schubert, W., Zhang, X. L., Marks, C. B., Macaluso, F., Russell, R. G., Li, M., Pestell, R. G., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105408200 · Cited by 1,158
Self-citationLin, E. Y., Jones, J. G., Li, P., Zhu, L., Whitney, K. D., Muller, W. J., & Pollard, J. W. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63568-7 · Cited by 1,107
Self-citationCell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independent
Derossi, D., Calvet, S., Trembleau, A., Brunissen, A., Chassaing, G., & Prochiantz, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.18188 · Cited by 1,073
Lundberg, A. S., & Weinberg, R. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.753 · Cited by 1,067
Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation.
Pagès, G., Lenormand, P., L'Allemain, G., Chambard, J. C., Meloche, S., & Pouysségur, J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8319 · Cited by 984
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A., & Schmidt, E. V. (1994) · Nature · doi:10.1038/369669a0 · Cited by 965
Hazan, R. B., Phillips, G. R., Qiao, R. F., Norton, L., & Aaronson, S. A. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.4.779 · Cited by 933
Self-citationIdentification of Peptide and Protein Ligands for the Caveolin-scaffolding Domain
Couet, J., Li, S., Okamoto, T., Ikezu, T., & Lisanti, M. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6525 · Cited by 918
Self-citationReduced angiogenesis and tumor progression in gelatinase A-deficient mice.
Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., & Itohara, S. (1998) · PubMed · Cited by 875
Transforming p21 Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions
Albanese, C., Johnson, J., Watanabe, G., Eklund, N., Vu, D., Arnold, A., & Pestell, R. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23589 · Cited by 803
Self-citationLi, S., Couet, J., & Lisanti, M. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29182 · Cited by 777
Self-citationTrojan peptides: the penetratin system for intracellular delivery
Derossi, D., Chassaing, G., & Prochiantz, A. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)80017-2 · Cited by 722
Interaction of a Receptor Tyrosine Kinase, EGF-R, with Caveolins
Couet, J., Sargiacomo, M., & Lisanti, M. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30429 · Cited by 664
Self-citationLu, Z., Ghosh, S., Wang, Z., & Hunter, T. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00304-0 · Cited by 647
Direct Interaction of Endothelial Nitric-oxide Synthase and Caveolin-1 Inhibits Synthase Activity
Ju, H., Zou, R., Venema, V. J., & Venema, R. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18522 · Cited by 640
Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis
Lisanti, M. P., Scherer, P. E., Tang, Z., & Sargiacomo, M. (1994) · Trends in Cell Biology · doi:10.1016/0962-8924(94)90114-7 · Cited by 637
Self-citationReciprocal Regulation of Endothelial Nitric-oxide Synthase by Ca2+-Calmodulin and Caveolin
Michel, J. B., Feron, O., Sacks, D., & Michel, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.15583 · Cited by 613
Evidence for a Regulated Interaction between Heterotrimeric G Proteins and Caveolin
Li, S., Okamoto, T., Chun, M., Sargiacomo, M., Casanova, J. E., Hansen, S. H., Nishimoto, I., & Lisanti, M. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.26.15693 · Cited by 608
Self-citationMatrix metal loproteinases and the development of cancer
Coussens, L. M., & Werb, Z. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90178-7 · Cited by 568
Activation of ternary complex factor Elk-1 by MAP kinases.
Janknecht, R., Ernst, W. H., Pingoud, V., & Nordheim, A. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06204.x · Cited by 560
Kurzchalia, T. V., Dupree, P., Parton, R. G., Kellner, R., Virta, H., Lehnert, M., & Simons, K. (1992) · The Journal of cell biology · doi:10.1083/jcb.118.5.1003 · Cited by 559
A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor
Suyama, K., Shapiro, I., Guttman, M., & Hazan, R. B. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00150-2 · Cited by 515
Self-citationRole of MAP kinase in tumor progression and invasion
Reddy, K. B., Nabha, S. M., & Atanaskova, N. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023781114568 · Cited by 509
Reduction of caveolin and caveolae in oncogenically transformed cells.
Koleske, A. J., Baltimore, D., & Lisanti, M. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1381 · Cited by 499
Self-citationCardiff, R. D., Anver, M. R., Gusterson, B. A., Hennighausen, L., Jensen, R. A., Merino, M. J., Rehm, S., Russo, J., Tavassoli, F. A., Wakefield, L. M., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203277 · Cited by 489
Galbiati, F. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6633 · Cited by 471
Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells
Lee, S. W., Reimer, C. L., Oh, P., Campbell, D. B., & Schnitzer, J. E. (1998) · Oncogene · doi:10.1038/sj.onc.1201661 · Cited by 421
Engelman, J. A., Chu, C., Lin, A., Jo, H., Ikezu, T., Okamoto, T., Kohtz, D. S., & Lisanti, M. P. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00470-0 · Cited by 371
Self-citationGlenney, J. R., & Soppet, D. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10517 · Cited by 370
Tyrosine Phosphorylation of a 22-kDa Protein Is Correlated with Transformation by Rous Sarcoma Virus
Glenney, J. R. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47038-5 · Cited by 363
Scherer, P. E., Tang, Z., Chun, M., Sargiacomo, M., Lodish, H. F., & Lisanti, M. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.27.16395 · Cited by 355
Self-citationElevated expression of caveolin is associated with prostate and breast cancer.
Yang, G., Truong, L. D., Timme, T. L., Ren, C., Wheeler, T. M., Park, S. H., Nasu, Y., Bangma, C. H., Kattan, M. W., Scardino, P. T., et al. (1998) · PubMed · Cited by 331
Microvascular Hyperpermeability in Caveolin-1 (−/−) Knock-out Mice
Schubert, W., Frank, P. G., Woodman, S. E., Hyogo, H., Cohen, D. E., Chow, C.-W., & Lisanti, M. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205948200 · Cited by 319
Self-citationRole of Caveolin-1 in the Modulation of Lipolysis and Lipid Droplet Formation
Cohen, A. W., Razani, B., Schubert, W., Williams, T. M., Wang, X. B., Iyengar, P., Brasaemle, D. L., Scherer, P. E., & Lisanti, M. P. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1261 · Cited by 319
Self-citationExperimental metastasis is suppressed in MMP-9-deficient mice
Itoh, T., Tanioka, M., Matsuda, H., Nishimoto, H., Yoshioka, T., Suzuki, R., & Uehira, M. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006603723759 · Cited by 308
Induction of cyclin D1 overexpression by activated ras.
Filmus, J., Robles, A. I., Shi, W., Wong, M. J. H., Colombo, L. L., & Conti, C. J. (1994) · PubMed · Cited by 295
Knudsen, E. S., & Wang, J. Y. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.10.5771 · Cited by 286
Tamura, Y., Watanabe, F., Nakatani, T., Yasui, K., Fuji, M., Komurasaki, T., Tsuzuki, H., Maekawa, R., Yoshioka, T., Kawada, K., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9707582 · Cited by 284
Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker.
Yang, G., Truong, L. D., Wheeler, T. M., & Thompson, T. C. (1999) · PubMed · Cited by 283
Liu, J.-J., Chao, J.-R., Jiang, M.-C., Ng, S.-Y., Yen, J. J.-Y., & Yang-Yen, H.-F. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.7.3654 · Cited by 275
Bourguignon, L. Y. W., Gunja-Smith, Z., Iida, N., Zhu, H. B., Young, L. J. T., Muller, W. J., & Cardiff, R. D. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199807)176:1<206::aid-jcp22>3.0.co;2-3 · Cited by 270
Self-citationFiucci, G., Ravid, D., Reich, R., & Liscovitch, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205300 · Cited by 262
Transgenic Polyoma middle-T mice model premalignant mammary disease.
Maglione, J. E., Moghanaki, D. M., Young, L. J. T., Manner, C. K., Ellies, L. G., Joseph, S. O., Nicholson, B., Cardiff, R. D., & MacLeod, C. L. (2001) · PubMed · Cited by 256
Ho, C.-C., Huang, P.-H., Huang, H.-Y., Chen, Y.-H., Yang, P.-C., & Hsu, S.-M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64442-2 · Cited by 228
Invasion activating caveolin-1 mutation in human scirrhous breast cancers.
Hayashi, K., Matsuda, S., Machida, K., Yamamoto, T., Fukuda, Y., Nimura, Y., Hayakawa, T., & Hamaguchi, M. (2001) · PubMed · Cited by 221
Tahir, S. A., Yang, G., Ebara, S., Timme, T. L., Satoh, T., Li, L., Goltsov, A. A., Ittmann, M., Morrisett, J. D., & Thompson, T. C. (2001) · PubMed · Cited by 215
Determination of the prognostic value of cyclin D1 overexpression in breast cancer.
McIntosh, G. G., Anderson, J. J., Milton, I. D., Steward, M., Parr, A., Thomas, M. D., Henry, J. A., Angus, B., Lennard, T. W. J., & Horne, C. H. W. (1995) · PubMed · Cited by 214
Engelman, J. A., Lee, R. J., Karnezis, A., Bearss, D. J., Webster, M., Siegel, P., Muller, W. J., Windle, J. J., Pestell, R. G., & Lisanti, M. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20448 · Cited by 209
Self-citationThe Loss of Estrogen and Progesterone Receptor Gene Expression in Human Breast Cancer
Lapidus, R. G., Nass, S. J., & Davidson, N. E. (1998) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018778403001 · Cited by 192
Caveolin-1 Mutations (P132L and Null) and the Pathogenesis of Breast Cancer
Lee, H., Park, D. S., Razani, B., Russell, R. G., Pestell, R. G., & Lisanti, M. P. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64412-4 · Cited by 188
Self-citationLi, L., Yang, G., Ebara, S., Satoh, T., Nasu, Y., Timme, T. L., Ren, C., Wang, J., Tahir, S. A., & Thompson, T. C. (2001) · PubMed · Cited by 188
Gálvez, B. G., Matías-Román, S., Yáñez-Mó, M., Vicente-Manzanares, M., Sánchez-Madrid, F., & Arroyo, A. G. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-07-0516 · Cited by 180
Kortenjann, M., Thomae, O., & Shaw, P. E. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4815 · Cited by 179
Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer
Dickson, C., Fantl, V., Gillett, C., Brookes, S., Bartek, J., Smith, R., Fisher, C., Barnes, D., & Peters, G. (1995) · Cancer Letters · doi:10.1016/0304-3835(94)03676-a · Cited by 176
Deletion of the p27 Kip1 gene restores normal development in cyclin D1-deficient mice
Geng, Y., Yu, Q., Sicińska, E., Das, M., Bronson, R. T., & Siciński, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.194 · Cited by 174
MMP-2 Colocalizes with Caveolae on the Surface of Endothelial Cells
Puyraimond, A., Fridman, R., Lemesle, M., Arbeille, B., & Menashi, S. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5069 · Cited by 168
Liu, J.-F., Crépin, M., Liu, J.-M., Barritault, D., & Ledoux, D. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00350-9 · Cited by 167
Caveolin-1 Expression Enhances Endothelial Capillary Tubule Formation
Liu, J., Wang, X. B., Park, D. S., & Lisanti, M. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110354200 · Cited by 165
Self-citationCaveolin-1 inhibits breast cancer growth and metastasis
Sloan, E. K., Stanley, K. L., & Anderson, R. L. (2004) · Oncogene · doi:10.1038/sj.onc.1208062 · Cited by 161
Williams, T. M., Cheung, M. W.-C., Park, D. S., Razani, B., Cohen, A. W., Muller, W. J., Vizio, D. D., Chopra, N. G., Pestell, R. G., & Lisanti, M. P. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-08-0503 · Cited by 161
Self-citationCyclin D1Governs Adhesion and Motility of Macrophages
Neumeister, P., Pixley, F. J., Xiong, Y., Xie, H., Wu, K., Ashton, A. W., Cammer, M., Chan, A. Y., Symons, M. H., Stanley, E. R., et al. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.02-07-0102 · Cited by 161
Self-citationBrondello, J., McKenzie, F. R., Sun, H., Tonks, N. K., & Pouysségur, J. (1995) · PubMed · Cited by 154
The Cyclin D1 Gene Is Transcriptionally Repressed by Caveolin-1
Hulit, J., Bash, T., Fu, M., Galbiati, F., Albanese, C., Sage, D., Schlegel, A., Zhurinsky, J., Shtutman, M. S., Ben‐Ze'ev, A., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000321200 · Cited by 153
Self-citationLocalization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains
Annabi, B., Lachambre, M., Bousquet-Gagnon, N., Pagé, M., Gingras, D., & Béliveau, R. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530547 · Cited by 152
Galardy, R. E., Grobelny, D. W., Foellmer, H. G., & Fernandez, L. A. (1994) · PubMed · Cited by 140
Caveolin-1 Knockout Mice Show an Impaired Angiogenic Response to Exogenous Stimuli
Woodman, S. E., Ashton, A. W., Schubert, W., Lee, H., Williams, T. M., Medina, F. A., Wyckoff, J. B., Combs, T. P., & Lisanti, M. P. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64337-4 · Cited by 130
Self-citationPark, D. S., Lee, H., Frank, P. G., Razani, B., Nguyen, A., Parlow, A. F., Russell, R. G., Hulit, J., Pestell, R. G., & Lisanti, M. P. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.02-05-0071 · Cited by 124
Self-citationZhang, W., Razani, B., Altschuler, Y., Bouzahzah, B., Mostov, K. E., Pestell, R. G., & Lisanti, M. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909895199 · Cited by 122
Self-citationCaveolin-I, a putative tumour suppressor gene
Razani, B., Schlegel, A., Liu, J., & Lisanti, M. P. (2001) · Biochemical Society Transactions · doi:10.1042/bst0290494 · Cited by 116
Self-citationjunB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2.
Coffer, P. J., de Jonge, M., Mettouchi, A., Binétruy, B., Ghysdael, J., & Kruijer, W. (1994) · PubMed · Cited by 104
Cell transformation by the middle T-antigen of polyoma virus
Ichaso, N., & Dilworth, S. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204859 · Cited by 92
Williams, T. M., Lee, H., Cheung, M. W.-C., Cohen, A. W., Razani, B., Iyengar, P., Scherer, P. E., Pestell, R. G., & Lisanti, M. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402064200 · Cited by 88
Self-citationKruger, J. S., & Reddy, K. B. (2003) · PubMed · Cited by 83
Cited by
Nozawa, H., Chiu, C., & Hanahan, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601807103 · Cited by 923
Caveolin-1 in oncogenic transformation, cancer, and metastasis
Williams, T. M., & Lisanti, M. P. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00458.2004 · Cited by 511
Self-citationMatrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia
Poincloux, R., Lizárraga, F., & Chavrier, P. (2009) · Journal of Cell Science · doi:10.1242/jcs.034561 · Cited by 504
Overcoming anoikis – pathways to anchorage-independent growth in cancer
Guadamillas, M. C., Cerezo, A., & del Pozo, M. A. (2011) · Journal of Cell Science · doi:10.1242/jcs.072165 · Cited by 426
Martinez-Outschoorn, U. E., Lisanti, M. P., & Sotgia, F. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.01.005 · Cited by 423
Self-citation
Metadata
- Authors
- Williams, T. M., Medina, F., Badano, I., Hazan, R. B., Hutchinson, J., Muller, W. J., Chopra, N. G., Scherer, P. E., Pestell, R. G., & Lisanti, M. P.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-12
- Volume
- 279
- Issue
- 49
- Pages
- 51630-51646
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2034464608
- Cited by
- 280
- References
- 84
- FWCI
- 7.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.